Dear Dr. Jonathan A Eisen,
The purpose of this letter is to invite you to be as a Speaker for the upcoming 6th
International Conference & Expo on Proteomics during – Atlanta, USA.
The aim to deliver a global platform to share knowledge and expertise with the scientific
community on the advancements in the field of Proteomics. The conference anticipates
leading worldwide researchers, scientists, academic scientists, industry researchers, scholars,
decision makers and other professionals from across the globe.
The theme of the conference is Revealing The Novel Innovation of Life Science, To Meet
1. Personal interaction with the Organizing Committee Members, Keynote speakers and other
eminent personalities for our future course of work.
2. Opportunity to conduct workshop/symposium with your team and colleagues based on your
Some confirmed speakers for World Proteomics 2016:
Steven Pelech, President of Kinexus Bioinformatics Corp, Canada.
Krishna Dronamraju, President of Foundation for Genetic Research, USA.
Desmond Fitzgerald, Vice-President for Health Affairs, UCD, Ireland.
Laszlo Takacs, CEO of Biosystems International Kft, Hungary.
Cheorl-Ho Kim, Director, Sungkyunkwan University, Republic of Korea.
Sixue Chen, Director of Proteomics, University of Florida, USA.
Jochen Schwenk, KTH – Royal Institute of Technology, Sweden.
S.K. Jain, Head of Biochemistry, Hamdard University, India.
Raju Ravikumar, Professor, NIMHANS University, India.
Kian Kani, University of Southern California, USA
Ahmed Aldarmahi, King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia.
For more details please visit http://www.proteomicsconference.com/america/
In closing, we would be pleased and honored if you would consent to be speaker at the World
Proteomics 2016 Conference.
I look forward to receiving your reply
Please feel free to contact us for further details on the conference.
Mark Henry Jane
5716 Corsa Ave, Suite110
Westlake, Los Angeles
Wow — just got an email invitation to one of those SPAMMY conferences. I quote the beginning below with the key part highlighted. There really is nothing else to say.
Dear Dr. Jonathan Eisen ,
On behalf of the organizing committee, we cordially invite you to propose a Speech as the Session Chair on your recent drug discovery project in the field of Benjamin Franklin Award Presentation for the Session 803: Database, Data Integration, Knowledge Management and Informatics Platform for Drug R & D of the Stream 8: Bio-IT and Data Management in Drug Discovery at the 12th Annual Congress of International Drug Discovery Science & Technology (IDDST-2014) with the theme “Shaping the Bright Future of Drug Discovery”, which will be held during November 21-23, 2014, Suzhou, China. Your prompt reply with a speech proposal will be highly appreciated! With your support, we hope to make this year event different from any others.
Just got an announcement for a meeting from Elsevier that I have absolutely no potential connection too. It is yet another example of Science Conference Spam. Not really shocking to get it from Elsevier to be honest. But one part of the email struck me. This was the end of the message which I post below:
DATA PROTECTION NOTICE
We obtained your name and email address from ISI Thomson Scientific, 3501 Market street, Philadelphia, PA 19104 USA. If you wish to be removed from the ISI Thomson Scientific mailing lists, please click here ISI Thomson Scientific.
Copyright © 2012 Elsevier B.V. http://www.elsevier.com. registered office: Radarweg 29, 1043 NX Amsterdam, The Netherlands, under number 33156677, VAT number 002967455B65. All rights reserved.
I can guess what it says but fortunately for those like me that don’t read Dutch, Google offers to translate. So I clicked on that offer just to be sure: “Page not found.” Great policy. Maybe I am supposed to pay to access it? I note – I have not posted the actual original link in the email because it has what appears to be some tracking information embedded in it. This I guess is what one could call an empty promise of privacy?
Collection and Registration of Personal Information
We may request users of this Site to provide personal information. The information collected directly from a user may include contact information such as the user’s name, e-mail address, and postal address.
In order to access certain content and to make use of the full functionality and advanced personalization features of the Site we ask you to register by completing and submitting a registration form, which may request additional information, such as work setting or principal professional field.
Automatic Collection of Information
This Site automatically collects certain information from your web browser regarding your use of the Site. Examples of information collected automatically from all users include the Internet Protocol (“IP”) address used to connect your computer to the Internet; computer and connection information such as browser type and version, operating system, and platform; and full Uniform Resource Locator (“URL”) click stream data, including date and time, and content you viewed or searched for on the Site.
This Site also collects information through the use of “cookies” or similar technologies. Cookies are anonymous, unique alphanumeric identifiers sent to your browser from a website’s computers and stored on your computer’s hard drive. The type of information collected as a result of a cookie being stored on your computer is specific to your computer. “Session” cookies collect information about your use of the Site (e.g., whether you are logged in) and to give you a more personalized browsing experience and help you navigate the Site more efficiently from page to page. These cookies are temporary and are deleted when you close your browser. “Persistent” cookies gather statistical information about repeat usage from your computer or workstation. In general, cookies do not contain personally identifiable information, but when you furnish your personal information through the Site, this information may be linked to the non-personally identifiable data stored in cookies sent to your browser from the Site.
You can prevent your browser from accepting certain cookies, have the browser require your consent before a new cookie is placed in your browser, or block cookies altogether by accessing your browser’s privacy preferences menu. However, if you block cookies altogether, you may not be able to register, login to the Site, or make use of the full features and functionality of the Site.
How Personal Information Is Used
We use the personal information that you provide for such purposes as:
Completion and support of the activity for which the information was provided, such as allowing access to or delivery of our products or services, processing or fulfilling an order, or responding to your requests or inquiries;
Website and system administration, such as for the technical support of the Site and its computer system, including processing computer account information, information used in the course of securing and maintaining the Site, and verification of Site activity by the Site or its agents;
Tailoring or customizing content or design of the Site during a single visit to the Site and individualized personalization of the Site on repeat visits;
Research and development to enhance, evaluate and improve the Site and our products and services;
Pseudonymous analysis to create a profile used to determine the habits, interests or other characteristics of users for purposes of research, analysis and anonymous reporting; and
Communicating with you about changes or updates to the Site and our products and services and special offers, promotions or market research surveys.
We may on occasion also match or combine the personal information that you provide with information that we obtain from other sources or that is already in our records, whether collected online or offline or by predecessor or affiliated group companies, for such purposes.
Disclosure of Personal Information to Third Parties
Access to your personal information is restricted to our employees, agents, representatives, service providers, and entities for which we are acting as an agent, licensee or publisher, such as societies, for the purposes set forth above. Your personal information may be used by all of our trading names and affiliated group companies and transferred to other countries for processing. These countries may not have similar data privacy laws, but if we transfer your information in this way, we will take steps to ensure that your information continues to be protected.
We also may share your personal information with our affiliated group companies worldwide and/or with non-affiliated third parties that wish to send you information about their products and services that may be of interest to you. We will not pass your personal information to such third parties if you indicate that you do not wish us to do so.
If this site offers an online content database or learning service (“Service”) and you access the Service through an institution-sponsored subscription, your personal information and certain usage data gathered through the Service, such as the number of items you downloaded, any non-subscribed items you accessed, and test scores, may be shared with your institution for the purposes of usage analysis, subscription management, course management, and testing and remediation. If your institution is a corporation or other business entity, additional usage data, such as the types of records you viewed and the number of searches you ran, also may be shared for the purposes of cost attribution and departmental budgeting.
We will not otherwise disclose any personal information without your consent except under the following circumstances:
in response to subpoenas, court orders, or legal process, or to establish or exercise our rights to defend against legal claims;
if we believe it is necessary to investigate, prevent, or take action regarding illegal activities, suspected fraud, safety of person or property, violation of our policies, or as otherwise required by law; and
if Elsevier, this Site, or a related asset or line of business is acquired by, transferred to or merged with another company.
Access and Changes to Your Registration Information and Preferences
Registered users may access their identified contact information and other registration information and correct any discrepancies or update information upon log in at any time. The accuracy of such information is solely the responsibility of the user. No access is given to other data that may have been collected about users.
If you wish to receive alerts, newsletters, special offers or promotions from us, please indicate your preferences when you register or amend your preferences upon log in at any time. If you wish to cease receiving any of this information, amend your preferences either upon log in or by using the “opt-out” or unsubscribe option or other means provided within the communications you receive. We reserve the right to notify you of changes or updates to the Site whenever necessary.
Retention of Personal Information
We retain the personal information we collect from you for as long as the information is relevant to our business purposes or until you request that we remove the data.
Our Commitment to Data Security
We endeavor to keep your personal information confidential and protected against unauthorized access, loss, misuse or alteration through the use of appropriate administrative, physical and technical safeguards. The personal and demographic information about each user is stored on systems that are subject to appropriate physical and electronic security measures, and we limit employee access to and use of such information.
Questions, Complaints, and Dispute Resolution
Elsevier Data Protection Officer
Oxford OX5 1GB
Last revised: 28 May 2010
I don’t know about you but I am not feeling too comforted by this policy. For comparison here are some links to privacy policies of other science publishers:
- Science/AAAS | Science Magazine: About the Journal: Privacy/Legal
- BioMed Central | Privacy
Hard to tell if this is email I just got is about a SPAM Conference or not.
On behalf of the Conference Organizing Committee, I would like to inform you of the:
FOURTH INTERNATIONAL CONFERENCE ON SCIENCE IN SOCIETY
University of California, Berkeley, USA
17 – 19 November 2012
This conference addresses the social impacts, values, pedagogies, politics and economics of science. It is an inclusive forum that welcomes a breadth of perspectives on science from practitioners, teachers and researchers representing a wide range of academic disciplines.
The Science in Society Conference is held annually in different locations around the world. The Inaugural Science in Society Conference was held at the University of Cambridge United Kingdom, in 2009. The Conference was held at the Universidad Carlos III de Madrid, Madrid, Spain in 2010; and the Catholic University of America, Washington DC, USA in 2011.
In addition to Plenary Presentations from leading speakers in the field, the Science in Society Conference includes parallel presentations by practitioners, teachers and researchers. We invite you to respond to the conference Call-for-Papers. Presenters submit their written papers for publication in the peer refereed “International Journal of Science in Society”. If you are unable to attend the conference in person, virtual registrations are also available which allow you to submit a paper for refereeing and possible publication in the journal as well as the option of uploading a video presentation to our YouTube channel.
The deadline for the next round in the call for papers (a title and short abstract) is 21 February 2012. Future deadlines will be announced on the conference website after this date. Proposals are reviewed within two weeks of submission. Full details of the conference, including an online proposal submission form, may be found at the conference website: http://science-society.com/conference-2012/ .
We look forward to receiving your proposal and hope you will be able to join us in Berkeley, USA in August.
Just got an email from YAP (yet another publisher) recruiting articles for new journals. These ones seem just about as SPAMMY as some of the other recent ones to come out. Uggh. Double uggh. Email is posted below:
Got this invitation a minute ago:
Dear Dr.Jonathan Eisen,
I am Monica Fu from the organizing committee of the 4thAnnual World Congress of Vaccine. Cordially, we invite you to give an oral presentation at Session 418: Japanese Encephalitis, Junin, Hendra and Nipah Vaccines about your recent work. In order that you can learn the conference details and scientific program quickly, I am pleased to send you a conference brochure in the attachment. You are appreciated to reply me with a speech title to my email: email@example.com.
Certainly, if you have any questions about the conference, please do not hesitate to contact me.
Ms. Monica Fu
Organizing Committee of WCV-2012
Only a minor complication. Never worked on anything related to this. Ahh – I love science conference spam.
Wow. I get a lot of what one could call “Conference SPAM” with invitations to meetings that seem like nothing more than feedlots. But this one really takes the cake:
Dear Dr. Eisen JA.
It is with great pleasure that we invite you to attend the EPS Montreal International Gene Conference to be held November 3-4, 2011 in Montreal, Quebec, Canada. The conference will provide a forum for researchers in Genetics and Genomics to present cutting edge research and learn about the latest breakthroughs and technologies.
We would like to welcome you to our Conference as our valuable speaker and present your recent work and ideas of Environmental shotgun sequencing: its potential and challenges for studying the hidden world of microbes. that were published in PLoS Biol.. Please visit our website at http://www.epsglobal.ca and http://www.epswordlink.com for program details.
Montreal International Gene Conference is organized by EPS Global Medical development Inc. Professor Massaro, the editor-in-chief of the journal Cell Biochemistry and Biophysics (CBB) will be present at this event and call for submission of papers in this field. All of the papers presented in the conference may have a chance to be published in a special issue of Cell Biochemistry and Biophysics (CBB).
EPS Global Medical Development Inc. is a Canada-based biomedical consultant agency that promotes continuing academic education, knowledge transfer and scientific exchange through life sciences-oriented conferences. We are delighted to host the EPS Montreal International Gene Conference in Montreal in order to foster and promote excellence in Genetics and Genomics through education and research, and to provide leadership in promoting development of evidence-based clinical genetics and genomics as well as the basic research that supports these clinical advances.
We look forward to meeting you in Montreal and wish you all an enjoyable time.
Yao Lu, MD, PhD
Executive Chair of Montreal International Gene Conference 2011
President of EPS Global Medical Development Inc.
They are inviting me to present about a “recent” commentary paper I published in 2007. Umm – no thanks.